BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 6799985)

  • 21. [Duration of the antianginal effect of oral molsidomine in exertion angina. Double-blind, crossed and randomized study].
    Bordes P; Gimeno JV; Olagüe J; Ferrer J; Hernández M; Algarra F
    Rev Esp Cardiol; 1986; 39(2):138-42. PubMed ID: 3523649
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effects of 3-(beta-diethylaminoethyl)-4-methyl-7-carbothoxymethoxy-2-oxo-(1,2-chromene)-hydrochloride and nitroglycerin on cardiovascular dynamics in healthy and coronary diseased hearts].
    Pippig L; Schneider KW
    Arzneimittelforschung; 1965 Sep; 15(9):1008-19. PubMed ID: 4955785
    [No Abstract]   [Full Text] [Related]  

  • 23. Part I: pharmacologic and hemodynamic actions and interactions. Pharmacologic and hemodynamic mechanisms underlying the antianginal actions of verapamil.
    Singh BN; Chew CY; Josephson MA; Packer M
    Am J Cardiol; 1982 Oct; 50(4):886-93. PubMed ID: 6751064
    [No Abstract]   [Full Text] [Related]  

  • 24. Perhexiline maleate in angina pectoris. A controlled, double-blind clinical trial.
    Bleifer DJ; Bleifer SB; Okun R
    Geriatrics; 1972 Sep; 27(9):109-15. PubMed ID: 4626492
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug therapy of angina pectoris. Evaluation of various drugs by means of work tests].
    Kaltenbach M
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1304+. PubMed ID: 4991635
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease--a randomised, double-blind, placebo controlled, crossover trial.
    Budzyński J; Kłopocka M; Pulkowski G; Suppan K; Fabisiak J; Majer M; Swiatkowski M
    Int J Cardiol; 2008 Jul; 127(2):233-9. PubMed ID: 17689732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of timolol vs placebo on angina pectoris.
    Aronow WS; Turbow M; Van Camp S; Lurie M; Whittaker K
    Circulation; 1980 Jan; 61(1):66-9. PubMed ID: 6765920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of nitrates in the treatment of ischemia].
    Schwinger RH
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S6. PubMed ID: 10818994
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cardiovascular drugs. 7/12. Nitrate derivatives].
    Berthou J; Limat S; Woronoff-Lemsi MC
    Soins; 2004 Nov; (690):55-6. PubMed ID: 15622648
    [No Abstract]   [Full Text] [Related]  

  • 31. Medical treatment of angina pectoris. 3. Pharmacology of sublingual nitrites as antianginal drugs.
    Aronow WS
    Am Heart J; 1972 Aug; 84(2):273-5. PubMed ID: 4627570
    [No Abstract]   [Full Text] [Related]  

  • 32. [Aerobic and hemodynamic mechanisms of the antianginal effect of drugs in patients with angina pectoris].
    Vasil'ev AP; Strel'tsova NN
    Klin Med (Mosk); 2004; 82(7):55-9. PubMed ID: 15449777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
    Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899
    [No Abstract]   [Full Text] [Related]  

  • 34. Short-term hemodynamic, anti-ischemic, and antianginal effects of pirsidomine, a new sydnonimine.
    Stengele E; Ruf G; Jähnchen E; Trenk D; Löffler K; Schulz W; Roskamm H
    Am J Cardiol; 1996 May; 77(11):937-41. PubMed ID: 8644642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effect of nitroglycerin on haemodynamics of angina pectoris.
    Arborelius M; Lecerof H; Malm A; Malmborg RO
    Br Heart J; 1968 May; 30(3):407-11. PubMed ID: 4967901
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug therapy in angina pectoris].
    Follath F
    Praxis (Bern 1994); 1995 Oct; 84(42):1186-9. PubMed ID: 7481332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new antianginal drug, bepridil: efficacy estimation by exertion test during a double blind test against a placebo (author's transl)].
    Canicave JC; Deu J; Jacq J; Paillet R
    Therapie; 1980; 35(5):607-12. PubMed ID: 6970998
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiology patient page. Nitroglycerin: the "mini" wonder drug.
    Graboys TB; Lown B
    Circulation; 2003 Sep; 108(11):e78-9. PubMed ID: 12975246
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological approaches to the therapy of angina.
    Parratt JR
    Adv Drug Res; 1974; 9():103-34. PubMed ID: 4156950
    [No Abstract]   [Full Text] [Related]  

  • 40. Effectiveness of nicorandil (SG-75), a new long-acting drug with nitroglycerin effects, in patients with coronary artery disease: improved left ventricular function and regional wall motion and abolition of pacing-induced angina.
    Thormann J; Schlepper M; Kramer W; Gottwik M; Kindler M
    J Cardiovasc Pharmacol; 1983; 5(3):371-7. PubMed ID: 6191134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.